Ramsay Generale dente (FRA:GD6) Debt-to-EBITDA : N/A (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GD6 Ramsay Generale de Sante SA FRA:GD6
71 GF Score
Price €10.75
GF Value €21.60
! 8 Warning Signs
View Full Analysis

What is Ramsay Generale dente Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ramsay Generale dente's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was €326 Mil. Ramsay Generale dente's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was €3,719 Mil. Ramsay Generale dente's annualized EBITDA for the quarter that ended in Dec. 2025 was €0 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ramsay Generale dente's Debt-to-EBITDA or its related term are showing as below:

FRA:GD6' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 4.38   Med: 6.55   Max: 7.35
Current: 6.07

During the past 13 years, the highest Debt-to-EBITDA Ratio of Ramsay Generale dente was 7.35. The lowest was 4.38. And the median was 6.55.

FRA:GD6's Debt-to-EBITDA is ranked worse than
79.87% of 477 companies
in the Healthcare Providers & Services industry
Industry Median: 2.22 vs FRA:GD6: 6.07

Ramsay Generale dente  (FRA:GD6) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ramsay Generale dente Debt-to-EBITDA Related Terms


Ramsay Generale dente Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Ramsay Generale dente's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ramsay Generale dente Debt-to-EBITDA Chart

Ramsay Generale dente Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.32 5.86 6.43 6.94 6.85

Ramsay Generale dente Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A -5.93 2.09 N/A 5.76

FRA:GD6 vs HCA, THC, DVA: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Ramsay Generale dente's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ramsay Generale dente Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ramsay Generale dente's Debt-to-EBITDA falls into.


FRA:GD6
71GF Score
Ramsay Generale de Sante SA FRA:GD6
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ramsay Generale dente Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ramsay Generale dente's Debt-to-EBITDA for the fiscal year that ended in Jun. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(335 + 3748.6) / 596
=6.85

Ramsay Generale dente's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(326.3 + 3719.3) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2025) EBITDA data.

Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued. The current stock price of €10.75 is trading 50.2% below its estimated GF Value™ of €21.60.

Key valuation signals for FRA:GD6:

  • Debt-to-EBITDA: N/A
  • GF Value™: €21.60 vs. price of €10.75 (50.2% below fair value)
  • GF Score™: 71/100 with 8 warning signs

No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ramsay Generale dente Business Description

Address 39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
71GF Score

Get the complete analysis for FRA:GD6

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.75
Price
€21.60
GF Value